Aptiv Solutions ADDPLAN® DF is the First Validated Software to Use MCP-Mod Methodology|
Thursday, October 31, 2013
MCP-Mod methodology was recently qualified by EMA for reducing bias and error in dose finding clinical trials.
Cobra Biologics Expands Antibody GMP Production Capacity
Tuesday, October 29, 2013
Company installs new 1000L HyClone SUB at the company’s centre of excellence.
Reducing Volume Losses During Fill and Finish
Thursday, October 24, 2013
Company will be presenting a poster at The Universe of Pre-Filled Syringes and Injection Devices PDA conference in Basel.
Cirrus - Kemwell Receives FDA Grant
Thursday, October 10, 2013
Grant to evaluate formulation effects on MDI performance.
Aesica Extends Aseptic Facilities at Nottingham Site
Tuesday, October 08, 2013
Batches can be delivered worldwide for clinical trials and within the EU for small-scale commercial production.
4SC Presents Summary of Biomarker and Patient Subgroup Analysis of Prognostic Factors
Tuesday, October 01, 2013
Further information about proposed role of biomarker ZFP64 in HCC tumour progression presented.
Almac Offering TruSight Tumor Profiling Next-Generation Sequencing Service
Monday, September 30, 2013
TruSight Tumor™ panel is specifically designed for use with FFPE samples.
Almac Launches SupplyTraQ™ Technology Solution
Tuesday, September 24, 2013
Online tool enables more cost-efficient and accurate reconciliation and reporting.
Aptiv Solutions Launches ADDPLAN® DF
Monday, September 23, 2013
An innovative software for optimizing dose selection in phase 2 trials.